- Product Details
Keywords
- 2-fluoro-4-(7-((quinolin-6-yl)methyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzoic acid
- 2-fluoro-4-(7-((quinolin-6-yl)methyl)imidazo(1,2-b)-(1,2,4)triazin-2-yl)benzamide
- 2-fluoro-n-methyl-4-(7-((quinolin-6-yl)methyl)imidazo(1,2- b)(1,2,4)triazin-2-yl)benzamide dihydrochloride monohydrate
Quick Details
- ProName: Capmatinib hydrochloride
- CasNo: 1865733-40-9
- Molecular Formula: C23H21Cl2FN6O2
- Appearance: light yellow powder
- Application: Met kinase inhibitor
- DeliveryTime: 2 month
- PackAge: fiber can
- Port: shanghai port
- ProductionCapacity: 200 Kilogram/Year
- Purity: 99%
- Storage: room temperature
- Transportation: air transport
- LimitNum: 1 Kilogram
- Related Substances: ≤0.1%
- Residue on Ignition: ≤0.2%
- Heavy Metal: ≤20ppm
- Valid Period: 2years
Superiority
The quality of our products is guaranteed and the price is low!
Details
CAS号:1865733-40-9
英文名:Capmatinibhydrochloride
英文别名:INC-2802HCl.H2O;INCB280602HCl.H2O;NVP-INC2802HCl.H2O;Capmatinib2HCl.H2O;Capmatinibhydrochloride;CapmatinibhydrochlorideHydrate;CapmatinibHClhydrate(INCB-28060;Capmatinibdihydrochloridehydrate;CapmatinibHydrChemicalbookochlorideHydrate(INCB28060);2-fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamidedihydrochloridemonohydrate
中文名:盐酸卡玛替尼一水合物中文别名:盐酸卡玛替尼;盐酸卡玛替尼一水合物;盐酸卡马替尼一水合物;
化合物CAPMATINIB2HCL.H2O
CBNumber:CB04848242
分子式:C23H20ClFN6O2
分子量:466.9
In Vitro: INCB28060 inhibits c-MET phosphorylation with an IC50 value of approximately 1 nM and a concentration of approximately 4 nM inhibits c-MET more than 90%, which is reversible and the effect is significantly reduced in several hours after the compound is removed and completely disappeared by 48 hours.
INCB28060 (0-10000 nM; 72 h) inhibits the proliferation of SNU-5, S114, H441 and U-87MG.
INCB28060 (0.06-62.25 nM; 2h) effectively inhibits phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, GAB1, and STAT3/5.
INCB28060 (0.24-63 nM; Over night) prevents HGF-stimulated H441 cell migration.
INCB28060 (0.5-50 nM; 20 min) suppresses phosphorylation of both EGFR and HER-3 rapidly.
In Vivo: INCB28060 (1-30 mg/kg; PO, twice daily, for 2 weeks) exhibits dose-dependent inhibition of tumor growth, and shows well tolerance at all doses during the treatment periods, with no evidence of overt toxicity or weight loss in U-87MG tumor mice model.
INCB28060 (0.03-10 mg/kg; PO, single dosage) causes inhibition of c-MET phosphorylation in S114 tumor mice model.